Nucleic Acid Integrated Technologies for Electrochemical Point‐of‐Care Diagnostics: A Comprehensive Review
- 18 August 2021
- journal article
- review article
- Published by Wiley in Electroanalysis
- Vol. 34 (2) , 148-160
Abstract
The need for routine and immediate healthcare monitoring has inspired “near‐patient testing” or in other words “point‐of‐care testing (POCT)”. Therefore, POCT can be defined as laboratory tests that are performed at the patient's bedside or in the immediate vicinity of the incident. Among many POCTs, nucleic acid‐based testing has attracted enormous attention for the diagnosis of important genetic, inherited and infectious diseases such as cancer and coronavirus. In this review, we outline the integration of nucleic acids into the remarkable electrochemical point‐of‐care diagnostics including microfluidic, paper and smartphone‐based approaches, CRISPR/Cas and liquid biopsy related systems and DNA damage monitoring.Keywords
This publication has 118 references indexed in Scilit:
- Potentiometric and voltammetric polymer lab chip sensors for determination of nitrate, pH and Cd(II) in waterTalanta, 2010
- Glucose Biosensors: An Overview of Use in Clinical PracticeSensors, 2010
- Electrochemical biosensorsChemical Society Reviews, 2010
- Indicator-based and indicator-free magnetic assays connected with disposable electrochemical nucleic acid sensor systemTalanta, 2009
- Electrochemical Biosensing of DNA Immobilized Poly(Vinylferrocenium) Modified ElectrodeElectroanalysis, 2008
- Simple Telemedicine for Developing Regions: Camera Phones and Paper-Based Microfluidic Devices for Real-Time, Off-Site DiagnosisAnalytical Chemistry, 2008
- Global health diagnosticsNature, 2006
- Future lab-on-a-chip technologies for interrogating individual moleculesNature, 2006
- Electrochemical Coding Technology for Simultaneous Detection of Multiple DNA TargetsJournal of the American Chemical Society, 2003
- Diagnostic Efficiency of Home Pregnancy Test Kits: A Meta-analysisArchives of Family Medicine, 1998